ambrisentan 10 MG Oral Tablet
1 INDICATIONS AND USAGE Ambrisentan tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1): To improve exercise ability and delay clinical worsening. In combination with tadalafil to reduce the risks of disease progression and hospitalization for worsening PAH, and to improve exercise ability [see Clinical Studies ( 14.2 )] . Studies establishing effectiveness included predominantly patients with WHO Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%). Ambrisentan is an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1): To improve exercise ability and delay clinical worsening. In combination with tadalafil to reduce the risks of disease progression and hospitalization for worsening PAH, and to improve exercise ability. Studies establishing effectiveness included trials predominantly in patients with WHO Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%) ( 1 ).
actavis pharma, inc.
OVAL WHITE 10 406
Related Pills
ambrisentan 10 MG Oral Tablet
actavis pharma, inc.
ambrisentan 5 MG Oral Tablet
actavis pharma, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
AMBRISENtan film - coated tablets are supplied as follows: Tablet Strength Package Configuration NDC No. Description of Tablet; debossed on Tablet; Size 5 mg 30 count bottle 0591 - 2405 - 30 white to off-white; capsule shaped; film- coated tablet; debossed with "5" on one side and "405" on the other side; 8.0 mm x 4.0 mm 10 mg 30 count bottle 0591 - 2406 - 30 white to off-white; capsule shaped; film- coated tablet; debossed with " 10 " on one side and "406" on the other side; 11.00 mm x 5.10 mm Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Store
AMBRISENtan tablets in its original packaging.
More pills like OVAL 10 406